Ohioensin F suppresses TNF-α-induced adhesion molecule expression by inactivation of the MAPK, Akt and NF-κB pathways in vascular smooth muscle cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hye-Eun Byeon | - |
dc.contributor.author | Yim, Joung Han | - |
dc.contributor.author | Suhkneung Pyo | - |
dc.contributor.author | Lee, Hong Kum | - |
dc.contributor.author | Sung Hee Um | - |
dc.date.accessioned | 2018-03-20T13:48:15Z | - |
dc.date.available | 2018-03-20T13:48:15Z | - |
dc.date.issued | 2012 | - |
dc.identifier.uri | https://repository.kopri.re.kr/handle/201206/6284 | - |
dc.description.abstract | The expression of cell adhesion molecules on vascular smooth muscle cells is central to leukocyte re- 23 cruitment and progression of atherosclerotic disease. Ohioensin F, a chemical compound of the Antarctic 24 moss Polytrichastrum alpinum, exhibited inhibitory activity against protein tyrosine phosphatase 1B and an- 25 tioxidant activity. However, published scientific information regarding other biological activities and phar- 26 macological function of ohioensin F is scarce. In the present study, we aimed to examine the in vitro 27 effects of ohioensin F on the ability to suppress TNF-α-induced adhesion molecule expression in vascular 28 smooth muscle cells (VSMCs). 29 Main methods: The inhibitory effect of ohioensin F on TNF-α-induced upregulation in expression of adhesion 30 molecules was investigated by enzyme-linked immunosorbent assay, cell adhesion assay, RT- PCR, western 31 blot analysis, immunofluorescence, and transfection and reporter assay, respectively. 32 Key findings: Pretreatment of VSMCs with ohioensin F at nontoxic concentrations of 0.1?10 μg/ml dose- 33 dependently inhibited TNF-α-induced expression of vascular cell adhesion molecule-1 (VCAM-1) and inter- 34 cellular adhesion molecule-1 (ICAM-1). In addition, ohioensin F suppressed adhesion of THP-1 monocytes to 35 TNF-α-stimulated VSMCs. Ohioensin F reduced TNF-α-induced production of intracellular lpinum, exhibited inhibitory activity against protein tyrosine phosphatase 1B and an- 25 tioxidant activity. However, published scientific information regarding other biological activities and phar- 26 macological function of ohioensin F is scarce. In the present study, we aimed to examine the in vitro 27 effects of ohioensin F on the ability to suppress TNF-α-induced adhesion molecule expression in vascular 28 smooth muscle cells (VSMCs). 29 Main methods: The inhibitory effect of ohioensin F on TNF-α-induced upregulation in expression | - |
dc.language | English | - |
dc.publisher | Elesevier | - |
dc.subject | Pharmacology & Pharmacy | - |
dc.title | Ohioensin F suppresses TNF-α-induced adhesion molecule expression by inactivation of the MAPK, Akt and NF-κB pathways in vascular smooth muscle cells | - |
dc.title.alternative | 평활근에서 오하이오신 f의 TNF-a 저해활성 | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | Hye-Eun Byeon, et al. 2012. "Ohioensin F suppresses TNF-α-induced adhesion molecule expression by inactivation of the MAPK, Akt and NF-κB pathways in vascular smooth muscle cells". <em>Life Sciences</em>, 90(11): 396-406. | - |
dc.citation.title | Life Sciences | - |
dc.citation.volume | 90 | - |
dc.citation.number | 11 | - |
dc.identifier.doi | 10.1016/j.lfs.2011.12.017 | - |
dc.citation.startPage | 396 | - |
dc.citation.endPage | 406 | - |
dc.description.articleClassification | SCI | - |
dc.description.jcrRate | JCR 2010:39.62264150943396 | - |
dc.subject.keyword | Anti-inflammation | - |
dc.subject.keyword | MAPK | - |
dc.subject.keyword | NF-κB | - |
dc.subject.keyword | Ohioensin F | - |
dc.subject.keyword | Vascular cell adhesion molecul | - |
dc.subject.keyword | Research & Experimental Medicine | - |
dc.identifier.localId | 2012-0133 | - |
dc.identifier.scopusid | 2-s2.0-84862788872 | - |
dc.identifier.wosid | 000301911200003 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.